Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Cytokine-cytokine receptor interaction (mmu04060)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK044424
KLA  ATP  ATP+KLA
 AK044424 adult retina cDNA, RIKEN full-length enriched library, clone:A930012B14 product:unclassifiable, full insert sequence [AK044424] KLA .92 .86 .88 .88 .95 .83 1.05
ATP .85 .68 .74 .72 .83 1.06 1.04
KLA/ATP .86 .74 .78 .74 .80 .99 1.07
Acvr1
KLA  ATP  ATP+KLA
 NM_007394 activin A receptor, type 1 (Acvr1), transcript variant 2, mRNA [NM_007394] KLA 2.86 2.67 2.99 2.33 1.67 1.27 1.19
ATP 1.08 1.12 .80 .69 .92 1.14 1.07
KLA/ATP 2.85 2.94 2.29 1.72 1.01 1.36 1.65
Acvr1b
KLA  ATP  ATP+KLA
 AK154578 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630048N11 product:activin A receptor, type 1B, full insert sequence [AK154578] KLA .92 .81 .83 1.45 2.62 1.73 1.65
ATP 1.06 1.05 .97 .57 1.31 2.68 1.19
KLA/ATP .72 .72 .90 .77 1.56 2.22 1.98
Acvr1b
KLA  ATP  ATP+KLA
 NM_007395 activin A receptor, type 1B (Acvr1b), mRNA [NM_007395] KLA 1.00 .95 .98 1.13 1.27 1.23 1.23
ATP 1.02 1.04 .96 .98 1.23 1.33 1.14
KLA/ATP .97 1.01 1.07 1.03 1.12 1.51 1.51
Acvr2a
KLA  ATP  ATP+KLA
 AK050252 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730031B13 product:hypothetical protein, full insert sequence. [AK050252] KLA .97 .95 1.02 1.08 1.00 1.08 1.10
ATP .97 1.00 .96 1.07 1.01 1.01 1.03
KLA/ATP .97 .95 .98 1.05 1.28 1.13 .95
Acvr2a
KLA  ATP  ATP+KLA
 NM_007396 activin receptor IIA (Acvr2a), mRNA [NM_007396] KLA 1.73 1.69 1.95 1.90 1.85 1.44 1.34
ATP .99 1.01 1.09 1.12 1.12 1.51 1.23
KLA/ATP 1.67 1.67 1.44 1.20 .95 1.29 1.72
Acvr2b
KLA  ATP  ATP+KLA
 NM_007397 activin receptor IIB (Acvr2b), mRNA [NM_007397] KLA .67 .63 .74 .69 .73 .71 .68
ATP .90 .88 .87 .76 .79 .97 .80
KLA/ATP .63 .61 .72 .66 .77 .78 .71
Amh
KLA  ATP  ATP+KLA
 NM_007445 anti-Mullerian hormone (Amh), mRNA [NM_007445] KLA 1.02 .96 .94 1.02 1.03 .96 .97
ATP .95 1.06 1.00 1.21 .99 1.00 .98
KLA/ATP 1.01 .96 1.02 1.05 .94 .96 .97
Amhr2
KLA  ATP  ATP+KLA
 NM_144547 anti-Mullerian hormone type 2 receptor (Amhr2), mRNA [NM_144547] KLA .96 1.00 .96 1.01 1.11 1.23 1.22
ATP 1.00 1.06 1.12 1.34 1.56 1.31 1.09
KLA/ATP 1.05 .99 .98 1.19 2.37 1.86 1.66
Bmp2
KLA  ATP  ATP+KLA
 NM_007553 bone morphogenetic protein 2 (Bmp2), mRNA [NM_007553] KLA 1.18 1.19 1.30 1.16 1.02 1.07 .99
ATP 1.05 1.18 1.79 4.60 2.95 2.38 .96
KLA/ATP 1.26 1.52 1.77 2.64 1.78 1.47 .97
Bmp4
KLA  ATP  ATP+KLA
 NM_007554 bone morphogenetic protein 4 (Bmp4), mRNA [NM_007554] KLA 1.02 1.04 1.04 1.09 1.08 1.12 1.06
ATP .98 1.00 1.05 1.04 .94 .97 1.00
KLA/ATP .99 1.03 1.07 1.04 .99 .99 .97
Bmp7
KLA  ATP  ATP+KLA
 NM_007557 bone morphogenetic protein 7 (Bmp7), mRNA [NM_007557] KLA 1.00 .98 1.00 1.00 .99 1.00 1.00
ATP 1.00 .99 1.04 .97 1.01 1.01 1.01
KLA/ATP .98 .97 1.02 1.00 1.03 1.00 .99
Bmpr1a
KLA  ATP  ATP+KLA
 NM_009758 bone morphogenetic protein receptor, type 1A (Bmpr1a), mRNA [NM_009758] KLA .98 .98 .93 .89 .89 .92 1.00
ATP 1.03 .99 .98 .87 .97 1.08 1.03
KLA/ATP .99 1.00 .89 .85 .94 1.01 .92
Bmpr1b
KLA  ATP  ATP+KLA
 NM_007560 bone morphogenetic protein receptor, type 1B (Bmpr1b), mRNA [NM_007560] KLA .99 1.00 .93 .94 .98 .90 .94
ATP 1.11 1.06 .94 .95 .98 .88 .95
KLA/ATP .84 .92 .95 .90 .89 .90 .89
Bmpr2
KLA  ATP  ATP+KLA
 AK011534 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610024H22 product:unclassifiable, full insert sequence. [AK011534] KLA 1.17 1.10 1.17 1.35 1.31 1.08 .67
ATP 1.01 .89 .93 .55 .59 .82 .57
KLA/ATP 1.17 .99 1.12 .63 .74 .67 .50
Bmpr2
KLA  ATP  ATP+KLA
 AK140220 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230350M15 product:unclassifiable, full insert sequence [AK140220] KLA 1.21 1.16 1.17 1.25 1.42 .90 .98
ATP 1.20 1.22 .96 .97 .88 1.00 .76
KLA/ATP 1.20 1.36 .96 1.00 .84 .91 .94
Bmpr2
KLA  ATP  ATP+KLA
 NM_007561 bone morphogenic protein receptor, type II (serine/threonine kinase) (Bmpr2), mRNA [NM_007561] KLA 1.39 1.34 1.46 1.67 1.59 1.39 1.15
ATP .94 .95 1.10 .88 .91 1.24 1.31
KLA/ATP 1.33 1.36 1.39 1.13 1.15 1.34 2.01
Ccl1
KLA  ATP  ATP+KLA
 NM_011329 chemokine (C-C motif) ligand 1 (Ccl1), mRNA [NM_011329] KLA 1.03 1.04 1.07 1.10 1.03 1.03 1.10
ATP .99 .99 1.01 .99 1.02 .99 .93
KLA/ATP 1.06 1.08 1.04 1.03 .80 .96 1.00
Ccl11
KLA  ATP  ATP+KLA
 NM_011330 small chemokine (C-C motif) ligand 11 (Ccl11), mRNA [NM_011330] KLA 1.03 1.17 1.09 1.06 1.05 1.09 1.01
ATP .94 1.05 1.35 2.25 1.09 1.05 1.06
KLA/ATP 1.06 1.06 1.93 4.93 1.46 1.14 1.04
Ccl12
KLA  ATP  ATP+KLA
 NM_011331 chemokine (C-C motif) ligand 12 (Ccl12), mRNA [NM_011331] KLA 40.77 33.71 46.23 51.22 57.13 57.92 16.26
ATP 1.41 1.14 1.54 1.79 1.41 1.89 9.34
KLA/ATP 39.52 43.18 61.96 69.72 62.95 38.70 29.25
Ccl17
KLA  ATP  ATP+KLA
 NM_011332 chemokine (C-C motif) ligand 17 (Ccl17), mRNA [NM_011332] KLA 5.80 6.54 6.67 5.82 5.34 4.65 1.49
ATP 1.06 1.07 1.46 2.16 1.70 1.56 1.29
KLA/ATP 6.13 6.44 6.40 7.18 5.95 5.31 2.14
Ccl19
KLA  ATP  ATP+KLA
 NM_011888 chemokine (C-C motif) ligand 19 (Ccl19), mRNA [NM_011888] KLA 1.12 1.20 1.11 1.09 1.08 1.01 1.05
ATP .93 .99 1.01 1.01 .98 .95 1.03
KLA/ATP 1.12 1.21 1.16 1.13 1.08 .98 1.03
Ccl2
KLA  ATP  ATP+KLA
 NM_011333 chemokine (C-C motif) ligand 2 (Ccl2), mRNA [NM_011333] KLA 10.26 9.30 8.35 10.02 8.92 14.08 11.59
ATP 1.62 1.68 2.20 4.16 3.92 4.84 17.45
KLA/ATP 10.09 10.31 10.95 12.32 8.00 10.04 21.29
Ccl20
KLA  ATP  ATP+KLA
 NM_016960 chemokine (C-C motif) ligand 20 (Ccl20), mRNA [NM_016960] KLA 1.00 1.03 1.05 .98 1.02 1.06 1.08
ATP .98 1.01 1.05 1.11 1.04 1.03 1.02
KLA/ATP 1.06 .97 1.04 1.19 1.02 1.14 1.07
Ccl21b
KLA  ATP  ATP+KLA
 NM_011124 chemokine (C-C motif) ligand 21b (Ccl21b), mRNA [NM_011124] KLA 1.02 .97 .96 1.03 1.05 1.04 1.03
ATP .97 1.00 1.01 1.01 .94 1.03 1.01
KLA/ATP 1.08 .97 .96 1.00 1.06 1.03 1.02
Ccl22
KLA  ATP  ATP+KLA
 NM_009137 chemokine (C-C motif) ligand 22 (Ccl22), mRNA [NM_009137] KLA 2.72 3.55 5.08 2.98 3.72 1.76 1.17
ATP .98 1.01 1.20 1.21 1.44 1.44 1.15
KLA/ATP 3.64 4.28 2.52 3.64 2.47 2.27 1.32
Ccl24
KLA  ATP  ATP+KLA
 NM_019577 chemokine (C-C motif) ligand 24 (Ccl24), mRNA [NM_019577] KLA 8.39 10.31 8.99 8.13 7.85 6.70 2.42
ATP 1.07 1.07 1.43 1.55 2.08 10.12 7.27
KLA/ATP 8.67 10.73 9.89 10.16 7.70 7.70 6.46
Ccl25
KLA  ATP  ATP+KLA
 NM_009138 chemokine (C-C motif) ligand 25 (Ccl25), mRNA [NM_009138] KLA 1.12 1.13 1.03 1.14 1.19 1.50 1.35
ATP .97 .97 1.18 1.05 1.23 1.49 1.15
KLA/ATP 1.10 1.21 1.32 1.14 1.66 1.98 1.70
Ccl27
KLA  ATP  ATP+KLA
 NM_011336 chemokine (C-C motif) ligand 27 (Ccl27), transcript variant 1, mRNA [NM_011336] KLA .80 .85 .84 .81 .76 .71 .57
ATP .88 .77 .90 .81 .89 .79 .46
KLA/ATP .80 .81 .90 .80 .90 .82 .55
Ccl28
KLA  ATP  ATP+KLA
 NM_020279 chemokine (C-C motif) ligand 28 (Ccl28), mRNA [NM_020279] KLA .94 1.04 .95 1.00 .95 1.04 1.06
ATP 1.04 .98 1.01 .99 1.05 .99 1.09
KLA/ATP .98 .95 .95 1.03 1.06 .97 1.00
Ccl3
KLA  ATP  ATP+KLA
 NM_011337 chemokine (C-C motif) ligand 3 (Ccl3), mRNA [NM_011337] KLA 22.83 22.40 18.03 21.58 11.57 8.28 7.46
ATP 3.19 4.67 12.12 16.50 11.13 9.49 6.12
KLA/ATP 20.09 20.92 34.53 24.06 21.64 12.34 7.43
Ccl4
KLA  ATP  ATP+KLA
 NM_013652 chemokine (C-C motif) ligand 4 (Ccl4), mRNA [NM_013652] KLA 68.93 60.20 52.12 67.06 35.78 15.78 8.82
ATP 2.26 3.82 16.88 43.14 26.67 9.47 6.75
KLA/ATP 59.57 71.75 133.98 193.53 81.76 15.96 7.62
Ccl5
KLA  ATP  ATP+KLA
 M77747 rantes mRNA, complete cds. [M77747] KLA 63.18 60.41 56.25 63.63 58.00 66.51 67.20
ATP .91 1.08 1.25 1.90 4.34 16.10 26.07
KLA/ATP 55.92 63.34 72.91 65.68 70.81 71.97 81.34
Ccl5
KLA  ATP  ATP+KLA
 NM_013653 chemokine (C-C motif) ligand 5 (Ccl5), mRNA [NM_013653] KLA 40.31 35.22 27.92 38.59 29.29 37.98 28.83
ATP .86 .92 1.43 1.66 3.86 15.09 16.66
KLA/ATP 32.14 31.72 47.19 35.89 42.00 46.15 43.89
Ccl6
KLA  ATP  ATP+KLA
 NM_009139 chemokine (C-C motif) ligand 6 (Ccl6), mRNA [NM_009139] KLA .85 .90 .94 .99 1.09 .99 .61
ATP 1.08 1.10 .97 1.23 1.32 1.90 3.96
KLA/ATP .92 1.01 .81 .99 1.04 1.55 1.83
Ccl7
KLA  ATP  ATP+KLA
 NM_013654 chemokine (C-C motif) ligand 7 (Ccl7), mRNA [NM_013654] KLA 17.48 15.75 16.58 21.45 21.00 27.52 18.84
ATP 1.94 2.37 2.42 5.05 5.68 4.90 24.09
KLA/ATP 17.85 19.02 15.43 25.89 18.96 16.55 31.61
Ccl8
KLA  ATP  ATP+KLA
 NM_021443 chemokine (C-C motif) ligand 8 (Ccl8), mRNA [NM_021443] KLA 31.22 26.92 34.00 40.21 34.20 38.93 34.84
ATP 1.15 .93 1.43 1.60 1.78 2.89 30.88
KLA/ATP 30.86 28.87 45.73 35.24 41.83 42.79 55.40
Ccl9
KLA  ATP  ATP+KLA
 NM_011338 chemokine (C-C motif) ligand 9 (Ccl9), mRNA [NM_011338] KLA 3.82 4.17 4.36 4.26 5.84 5.09 2.07
ATP 1.03 1.05 .96 1.13 1.54 2.91 6.92
KLA/ATP 3.99 4.19 2.82 3.51 2.87 2.97 4.51
Ccr1
KLA  ATP  ATP+KLA
 NM_009912 chemokine (C-C motif) receptor 1 (Ccr1), mRNA [NM_009912] KLA 1.00 1.01 1.11 1.16 1.18 1.16 1.03
ATP 1.00 1.17 1.07 1.27 1.85 2.63 4.26
KLA/ATP .98 1.01 1.17 1.21 1.33 1.83 4.33
Ccr10
KLA  ATP  ATP+KLA
 NM_007721 chemokine (C-C motif) receptor 10 (Ccr10), mRNA [NM_007721] KLA 1.09 1.12 1.05 1.03 1.15 .97 .96
ATP .90 1.01 .97 .97 .98 1.02 1.00
KLA/ATP .97 .99 1.04 1.02 .97 .92 .97
Ccr1l1
KLA  ATP  ATP+KLA
 NM_007718 chemokine (C-C motif) receptor 1-like 1 (Ccr1l1), mRNA [NM_007718] KLA .91 .91 .93 .92 1.04 1.11 1.12
ATP 1.02 1.02 1.09 .98 .99 .98 1.36
KLA/ATP .99 .90 .89 .92 .91 .99 1.41
Ccr3
KLA  ATP  ATP+KLA
 NM_009914 chemokine (C-C motif) receptor 3 (Ccr3), mRNA [NM_009914] KLA 1.22 1.12 1.02 1.02 1.06 1.32 1.45
ATP 1.09 1.22 1.38 1.47 1.17 1.41 4.85
KLA/ATP 1.23 1.29 1.16 1.14 .80 .71 3.44
Ccr4
KLA  ATP  ATP+KLA
 NM_009916 chemokine (C-C motif) receptor 4 (Ccr4), mRNA [NM_009916] KLA .97 1.00 .99 1.00 1.06 1.06 1.05
ATP 1.03 .97 .98 1.05 .96 .99 1.07
KLA/ATP 1.01 1.01 .99 1.05 .98 .99 1.01
Ccr5
KLA  ATP  ATP+KLA
 NM_009917 chemokine (C-C motif) receptor 5 (Ccr5), mRNA [NM_009917] KLA .92 .90 1.34 1.58 1.78 1.69 2.02
ATP 1.09 1.04 1.14 1.01 .71 .62 1.40
KLA/ATP .96 .98 1.28 1.29 1.04 .67 1.57
Ccr6
KLA  ATP  ATP+KLA
 NM_009835 chemokine (C-C motif) receptor 6 (Ccr6), mRNA [NM_009835] KLA .99 1.01 1.06 1.00 .95 .97 .97
ATP 1.09 1.00 1.13 1.27 1.04 .99 .97
KLA/ATP 1.04 1.02 1.18 1.21 .98 .91 .97
Ccr7
KLA  ATP  ATP+KLA
 NM_007719 chemokine (C-C motif) receptor 7 (Ccr7), mRNA [NM_007719] KLA 1.58 1.73 2.00 1.95 2.02 1.77 1.60
ATP 1.07 1.06 1.21 2.11 2.85 2.72 1.78
KLA/ATP 1.76 1.95 3.23 4.65 5.17 5.76 4.07
Ccr8
KLA  ATP  ATP+KLA
 NM_007720 chemokine (C-C motif) receptor 8 (Ccr8), mRNA [NM_007720] KLA 1.05 .96 .95 1.04 1.02 1.05 1.02
ATP .98 1.02 1.06 1.00 .98 1.03 1.05
KLA/ATP .92 .93 1.02 .99 1.00 .97 1.11
Ccr9
KLA  ATP  ATP+KLA
 NM_009913 chemokine (C-C motif) receptor 9 (Ccr9), mRNA [NM_009913] KLA 1.49 1.42 1.94 1.73 1.61 1.31 1.26
ATP 1.19 1.03 1.17 1.26 1.34 1.41 1.12
KLA/ATP 1.58 1.64 1.64 1.64 1.40 1.41 1.42
Cd27
KLA  ATP  ATP+KLA
 NM_001033126 CD27 antigen (Cd27), transcript variant 1, mRNA [NM_001033126] KLA .98 1.03 1.00 1.02 1.06 1.01 1.06
ATP .99 1.03 1.04 1.00 1.02 1.06 1.07
KLA/ATP .97 .99 1.01 .98 1.04 1.02 1.05
Cd40
KLA  ATP  ATP+KLA
 NM_170701 CD40 antigen (Cd40), transcript variant 3, mRNA [NM_170701] KLA 23.87 23.62 23.26 23.98 22.07 17.37 5.34
ATP 1.00 1.01 1.06 2.96 2.65 3.03 1.70
KLA/ATP 22.77 23.79 29.67 28.85 28.08 21.62 13.02
Cd40lg
KLA  ATP  ATP+KLA
 NM_011616 CD40 ligand (Cd40lg), mRNA [NM_011616] KLA 1.03 1.07 1.02 .98 1.06 1.06 1.03
ATP .95 .92 .99 1.06 1.02 1.04 1.07
KLA/ATP 1.00 1.01 .93 1.04 .94 1.01 .98
Cd70
KLA  ATP  ATP+KLA
 NM_011617 CD70 antigen (Cd70), mRNA [NM_011617] KLA .93 .95 .98 1.05 1.07 1.05 1.04
ATP 1.09 .95 1.04 1.11 1.07 1.01 .98
KLA/ATP 1.03 .99 .93 1.07 1.02 1.03 .98
Clcf1
KLA  ATP  ATP+KLA
 NM_019952 cardiotrophin-like cytokine factor 1 (Clcf1), mRNA [NM_019952] KLA 1.48 1.45 1.55 1.52 1.55 1.40 1.32
ATP 1.04 1.05 1.19 1.85 3.78 2.93 1.44
KLA/ATP 1.59 1.68 1.51 1.76 3.88 3.35 2.61
Cntfr
KLA  ATP  ATP+KLA
 NM_016673 ciliary neurotrophic factor receptor (Cntfr), mRNA [NM_016673] KLA 1.03 1.03 1.08 1.06 1.05 .95 .95
ATP .89 .99 1.01 .96 .94 1.01 .95
KLA/ATP .93 .95 1.03 .96 1.00 .92 .95
Crlf2
KLA  ATP  ATP+KLA
 NM_016715 cytokine receptor-like factor 2 (Crlf2), mRNA [NM_016715] KLA 1.22 1.28 1.26 1.35 1.28 1.44 1.35
ATP .94 .87 1.11 .99 .95 1.07 .94
KLA/ATP 1.19 1.28 1.32 1.34 1.27 1.30 1.17
Csf1
KLA  ATP  ATP+KLA
 NM_007778 colony stimulating factor 1 (macrophage) (Csf1), transcript variant 1, mRNA [NM_007778] KLA 18.44 16.94 15.74 12.71 7.63 6.20 2.51
ATP 1.04 1.22 4.90 14.80 12.10 10.26 6.73
KLA/ATP 16.93 18.17 20.56 19.41 18.03 15.99 12.59
Csf1r
KLA  ATP  ATP+KLA
 NM_001037859 colony stimulating factor 1 receptor (Csf1r), mRNA [NM_001037859] KLA .76 .81 .88 .67 .74 .78 .90
ATP 1.10 1.22 .88 1.10 .87 .78 1.28
KLA/ATP .97 .87 .63 .83 .51 .66 1.18
Csf2
KLA  ATP  ATP+KLA
 NM_009969 colony stimulating factor 2 (granulocyte-macrophage) (Csf2), mRNA [NM_009969] KLA 1.44 1.53 1.38 1.37 1.15 1.21 1.14
ATP 1.01 1.02 1.85 9.73 2.64 1.90 1.14
KLA/ATP 1.49 1.84 2.14 2.80 1.67 1.36 1.35
Csf2ra
KLA  ATP  ATP+KLA
 NM_009970 colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (Csf2ra), mRNA [NM_009970] KLA 1.10 1.06 1.03 1.13 1.24 1.35 1.09
ATP .89 .87 .95 .81 .86 1.10 1.06
KLA/ATP .94 .98 1.22 1.02 1.18 1.11 1.22
Csf2rb
KLA  ATP  ATP+KLA
 NM_007780 colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) (Csf2rb), mRNA [NM_007780] KLA 1.35 1.52 1.85 1.87 2.61 2.52 2.54
ATP 1.09 1.15 1.08 1.83 6.59 6.78 7.07
KLA/ATP 1.55 1.66 1.38 2.67 6.21 6.94 6.57
Csf2rb2
KLA  ATP  ATP+KLA
 NM_007781 colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) (Csf2rb2), mRNA [NM_007781] KLA .78 .77 .81 1.04 1.45 1.45 1.91
ATP 1.12 1.03 .89 1.11 6.65 7.45 8.58
KLA/ATP .87 .87 .84 1.09 4.89 7.15 8.83
Csf3
KLA  ATP  ATP+KLA
 NM_009971 colony stimulating factor 3 (granulocyte) (Csf3), mRNA [NM_009971] KLA 1.44 1.56 2.06 2.25 2.97 1.58 1.55
ATP 1.04 1.05 1.14 2.18 4.85 7.52 1.83
KLA/ATP 1.54 1.93 2.57 4.75 3.85 3.95 7.39
Csf3r
KLA  ATP  ATP+KLA
 NM_007782 colony stimulating factor 3 receptor (granulocyte) (Csf3r), mRNA [NM_007782] KLA 4.44 4.65 6.62 6.79 9.58 9.08 7.39
ATP 1.27 1.26 1.06 1.43 1.13 1.07 1.28
KLA/ATP 5.07 5.53 4.84 7.70 3.86 3.49 7.22
Ctf1
KLA  ATP  ATP+KLA
 NM_007795 cardiotrophin 1 (Ctf1), mRNA [NM_007795] KLA 1.00 1.05 1.06 .92 .96 .97 .93
ATP .93 .93 1.01 .96 1.00 .92 1.02
KLA/ATP 1.00 1.07 .98 .99 .87 .90 .87
Cx3cl1
KLA  ATP  ATP+KLA
 AB030188 mRNA, complete cds, clone:1-53. [AB030188] KLA 1.04 .94 1.03 1.04 .92 1.05 1.00
ATP .94 .96 .98 .96 1.02 .91 1.04
KLA/ATP 1.03 .99 .96 .98 .89 1.03 .99
Cx3cl1
KLA  ATP  ATP+KLA
 NM_009142 chemokine (C-X3-C motif) ligand 1 (Cx3cl1), mRNA [NM_009142] KLA 20.22 19.73 16.74 16.02 9.46 3.82 .33
ATP .91 .89 1.19 1.28 1.33 1.21 .55
KLA/ATP 17.11 18.99 24.51 16.85 12.70 6.17 .69
Cx3cr1
KLA  ATP  ATP+KLA
 NM_009987 chemokine (C-X3-C) receptor 1 (Cx3cr1), mRNA [NM_009987] KLA .73 .75 .66 .75 .72 .66 .67
ATP .96 1.11 .96 .96 .67 .62 .71
KLA/ATP .70 .69 .67 .71 .63 .57 .69
Cxcl1
KLA  ATP  ATP+KLA
 NM_008176 chemokine (C-X-C motif) ligand 1 (Cxcl1), mRNA [NM_008176] KLA 36.87 30.25 15.74 8.84 5.41 3.01 5.84
ATP 2.77 8.26 128.38 289.44 262.38 218.83 26.91
KLA/ATP 41.06 56.76 91.82 164.83 91.44 77.89 79.05
Cxcl10
KLA  ATP  ATP+KLA
 NM_021274 chemokine (C-X-C motif) ligand 10 (Cxcl10), mRNA [NM_021274] KLA 986.69 854.98 711.49 799.39 542.62 686.82 183.27
ATP .98 1.71 9.85 73.04 100.42 184.63 8.33
KLA/ATP 842.13 793.12 ###.## ###.## ###.## 715.22 496.10
Cxcl11
KLA  ATP  ATP+KLA
 NM_019494 chemokine (C-X-C motif) ligand 11 (Cxcl11), mRNA [NM_019494] KLA 53.93 53.81 51.26 58.57 51.83 57.67 21.56
ATP 1.04 1.02 1.56 1.81 1.84 5.79 2.13
KLA/ATP 48.25 51.73 69.50 55.47 41.98 48.57 57.88
Cxcl12
KLA  ATP  ATP+KLA
 NM_001012477 chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 3, mRNA [NM_001012477] KLA .91 .91 .92 .92 .91 1.00 .85
ATP 1.00 .99 1.02 .99 .91 .93 .88
KLA/ATP .89 .91 .97 .97 .94 .93 .82
Cxcl12
KLA  ATP  ATP+KLA
 NM_021704 chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 1, mRNA [NM_021704] KLA 1.01 .96 1.04 1.04 .94 .98 .94
ATP 1.01 .92 .98 1.04 1.02 .94 .98
KLA/ATP 1.02 .98 1.07 .95 1.02 .98 .99
Cxcl13
KLA  ATP  ATP+KLA
 NM_018866 chemokine (C-X-C motif) ligand 13 (Cxcl13), mRNA [NM_018866] KLA 1.03 1.04 .98 1.05 .94 1.08 1.05
ATP 1.04 1.05 .99 1.13 1.04 1.04 1.03
KLA/ATP 1.01 1.06 .95 1.09 .98 1.02 .98
Cxcl14
KLA  ATP  ATP+KLA
 NM_019568 chemokine (C-X-C motif) ligand 14 (Cxcl14), mRNA [NM_019568] KLA 1.02 1.13 .93 .93 .88 .85 .82
ATP .86 1.01 1.26 1.47 1.30 1.29 1.32
KLA/ATP 1.04 1.07 1.02 1.38 1.12 1.30 1.30
Cxcl15
KLA  ATP  ATP+KLA
 NM_011339 chemokine (C-X-C motif) ligand 15 (Cxcl15), mRNA [NM_011339] KLA .97 .96 .96 .99 1.01 1.00 1.03
ATP .99 .98 .99 .99 1.01 1.06 1.06
KLA/ATP 1.03 .99 .96 1.02 .98 1.04 1.01
Cxcl16
KLA  ATP  ATP+KLA
 NM_023158 chemokine (C-X-C motif) ligand 16 (Cxcl16), mRNA [NM_023158] KLA 3.78 3.78 3.46 3.55 3.95 4.13 3.72
ATP .92 .87 .83 1.17 1.40 1.91 2.65
KLA/ATP 3.43 3.23 2.89 3.40 3.06 3.23 5.63
Cxcl2
KLA  ATP  ATP+KLA
 NM_009140 chemokine (C-X-C motif) ligand 2 (Cxcl2), mRNA [NM_009140] KLA 20.11 17.63 13.50 7.78 9.14 3.98 10.85
ATP 10.96 27.84 145.37 396.18 303.88 165.35 21.04
KLA/ATP 33.28 74.00 189.99 348.56 93.84 68.75 64.87
Cxcl3
KLA  ATP  ATP+KLA
 NM_203320 chemokine (C-X-C motif) ligand 3 (Cxcl3), mRNA [NM_203320] KLA 35.82 43.91 31.09 16.74 3.98 2.27 2.93
ATP 1.13 1.23 3.43 12.43 126.40 310.60 215.03
KLA/ATP 36.32 44.70 46.93 50.61 18.91 95.89 296.64
Cxcl5
KLA  ATP  ATP+KLA
 NM_009141 chemokine (C-X-C motif) ligand 5 (Cxcl5), mRNA [NM_009141] KLA 1.27 1.29 1.18 1.21 1.14 1.07 1.08
ATP 1.02 .99 1.08 1.10 1.92 18.34 20.38
KLA/ATP 1.27 1.26 1.26 1.24 1.23 4.06 29.52
Cxcl9
KLA  ATP  ATP+KLA
 NM_008599 chemokine (C-X-C motif) ligand 9 (Cxcl9), mRNA [NM_008599] KLA 47.92 43.81 42.05 48.89 39.45 45.28 32.42
ATP 1.00 1.02 1.43 1.62 1.59 2.25 1.96
KLA/ATP 41.95 43.69 63.75 56.28 60.18 53.62 48.95
Cxcr3
KLA  ATP  ATP+KLA
 NM_009910 chemokine (C-X-C motif) receptor 3 (Cxcr3), mRNA [NM_009910] KLA .38 .33 .29 .28 .19 .17 .13
ATP .97 .92 1.27 1.14 .87 .36 .37
KLA/ATP .37 .37 .42 .42 .35 .24 .26
Cxcr4
KLA  ATP  ATP+KLA
 NM_009911 chemokine (C-X-C motif) receptor 4 (Cxcr4), mRNA [NM_009911] KLA .30 .34 .26 .31 .25 .29 .42
ATP 1.27 2.70 6.37 11.61 7.04 1.14 4.92
KLA/ATP .28 .34 .56 2.60 3.47 1.23 1.28
Cxcr5
KLA  ATP  ATP+KLA
 NM_007551 chemochine (C-X-C motif) receptor 5 (Cxcr5), mRNA [NM_007551] KLA 1.18 1.29 1.48 1.43 1.40 1.48 1.27
ATP 1.05 1.00 1.08 1.05 1.16 1.22 1.37
KLA/ATP 1.35 1.32 1.05 1.36 1.25 1.57 1.54
Cxcr6
KLA  ATP  ATP+KLA
 NM_030712 chemokine (C-X-C motif) receptor 6 (Cxcr6), mRNA [NM_030712] KLA 1.17 1.20 1.20 1.17 1.14 1.24 1.22
ATP .94 .97 1.00 1.14 1.36 1.38 1.05
KLA/ATP 1.21 1.21 1.13 1.30 2.09 3.33 3.08
Cxcr7
KLA  ATP  ATP+KLA
 NM_007722 chemokine (C-X-C motif) receptor 7 (Cxcr7), mRNA [NM_007722] KLA .96 .97 .97 .97 1.03 1.03 .95
ATP 1.06 1.00 1.07 .99 1.08 .98 1.07
KLA/ATP 1.02 1.00 1.01 1.04 1.05 1.10 1.06
Eda
KLA  ATP  ATP+KLA
 NM_010099 ectodysplasin-A (Eda), mRNA [NM_010099] KLA 1.04 1.01 1.08 1.02 .98 .94 1.04
ATP 1.06 1.08 1.06 .94 .94 .93 .93
KLA/ATP 1.14 1.06 1.11 .91 .99 1.02 .99
Eda2r
KLA  ATP  ATP+KLA
 AK029268 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832407L12 product:inferred: X-linked ectodysplasin-A2 receptor {Homo sapiens}, full insert sequence [AK029268] KLA 1.09 1.01 .99 1.07 .96 .87 .88
ATP 1.01 1.01 1.01 .97 .96 .95 .89
KLA/ATP 1.12 1.00 1.04 .96 1.03 .93 .89
Edar
KLA  ATP  ATP+KLA
 AF160502 ectodermal dysplasia receptor (dl) mRNA, complete cds [AF160502] KLA .99 1.03 .96 .94 1.02 1.03 1.01
ATP 1.05 1.04 .98 .97 1.03 1.05 1.05
KLA/ATP 1.02 .95 .98 1.00 1.06 1.00 .96
Egf
KLA  ATP  ATP+KLA
 NM_010113 epidermal growth factor (Egf), mRNA [NM_010113] KLA .89 .90 .81 .83 .83 .86 .92
ATP 1.03 1.03 .95 .84 .67 .79 .88
KLA/ATP .86 .86 .77 .77 .69 .78 .83
Egfr
KLA  ATP  ATP+KLA
 NM_007912 epidermal growth factor receptor (Egfr), transcript variant 2, mRNA [NM_007912] KLA 1.10 1.07 1.14 1.11 1.08 1.03 .90
ATP .99 1.00 1.04 .98 .97 1.15 1.14
KLA/ATP 1.07 1.10 1.16 1.08 1.01 .97 .94
Egfr
KLA  ATP  ATP+KLA
 NM_207655 epidermal growth factor receptor (Egfr), transcript variant 1, mRNA [NM_207655] KLA 1.57 1.44 1.47 1.31 .96 .92 .76
ATP .97 .93 1.10 1.00 1.41 2.97 .86
KLA/ATP 1.44 1.50 1.61 1.30 1.14 1.21 .82
Epo
KLA  ATP  ATP+KLA
 NM_007942 erythropoietin (Epo), mRNA [NM_007942] KLA 1.00 1.05 1.08 1.01 1.03 1.08 1.04
ATP .95 .97 .97 1.04 1.02 .99 1.01
KLA/ATP 1.03 1.01 .97 1.00 1.00 1.10 1.00
Epor
KLA  ATP  ATP+KLA
 NM_010149 erythropoietin receptor (Epor), mRNA [NM_010149] KLA .57 .56 .59 .66 .59 .52 .36
ATP 1.06 1.01 1.00 .95 .73 .52 .40
KLA/ATP .57 .53 .70 .66 .72 .62 .34
Fas
KLA  ATP  ATP+KLA
 AK086933 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030012O08 product:tumor necrosis factor receptor superfamily, member 6, full insert sequence. [AK086933] KLA 6.31 6.56 6.33 6.70 4.93 3.74 2.48
ATP .95 1.04 1.33 1.55 1.85 6.00 2.77
KLA/ATP 5.67 7.16 7.71 7.73 6.02 5.79 7.85
Fas
KLA  ATP  ATP+KLA
 NM_007987 Fas (TNF receptor superfamily member 6) (Fas), mRNA [NM_007987] KLA 17.08 17.45 19.08 17.38 13.33 6.78 4.46
ATP .98 .96 1.64 3.05 5.58 12.91 1.89
KLA/ATP 16.57 17.25 26.06 23.57 22.03 16.74 13.29
Fasl
KLA  ATP  ATP+KLA
 NM_010177 Fas ligand (TNF superfamily, member 6) (Fasl), mRNA [NM_010177] KLA 1.03 1.01 1.03 1.02 1.01 1.01 1.00
ATP 1.00 .99 1.04 1.21 1.18 1.20 1.01
KLA/ATP 1.00 1.02 1.07 1.16 1.18 1.23 1.00
Figf
KLA  ATP  ATP+KLA
 NM_010216 c-fos induced growth factor (Figf), mRNA [NM_010216] KLA .92 .95 .93 .87 .82 .87 .77
ATP 1.03 1.04 1.06 .90 1.13 2.02 .78
KLA/ATP .92 .94 .97 .85 .97 1.10 .92
Flt1
KLA  ATP  ATP+KLA
 NM_010228 FMS-like tyrosine kinase 1 (Flt1), mRNA [NM_010228] KLA 3.02 2.74 2.92 3.54 3.71 3.82 1.43
ATP .88 .85 1.07 .85 .94 1.31 1.16
KLA/ATP 2.60 2.99 3.08 2.13 2.23 2.00 2.59
Flt3
KLA  ATP  ATP+KLA
 NM_010229 FMS-like tyrosine kinase 3 (Flt3), mRNA [NM_010229] KLA .99 1.01 1.05 1.01 1.05 1.01 1.01
ATP .92 .98 1.09 1.12 1.00 1.02 1.03
KLA/ATP 1.04 .99 .89 1.01 .99 .94 1.05
Flt3l
KLA  ATP  ATP+KLA
 NM_013520 FMS-like tyrosine kinase 3 ligand (Flt3l), mRNA [NM_013520] KLA 1.08 1.12 1.37 1.32 1.68 1.86 1.67
ATP 1.08 1.03 1.05 1.22 .90 .71 1.26
KLA/ATP 1.12 1.16 1.20 1.22 1.09 .91 1.29
Flt4
KLA  ATP  ATP+KLA
 NM_008029 FMS-like tyrosine kinase 4 (Flt4), mRNA [NM_008029] KLA 1.04 1.02 1.01 1.00 1.10 1.01 1.01
ATP 1.02 1.08 1.07 .99 .95 .97 1.02
KLA/ATP 1.08 1.06 1.00 1.02 .99 1.07 1.02
Gdf5
KLA  ATP  ATP+KLA
 NM_008109 growth differentiation factor 5 (Gdf5), mRNA [NM_008109] KLA 1.00 .93 .91 .99 1.06 1.04 1.16
ATP .99 .98 .97 .98 .89 .97 1.01
KLA/ATP .88 .96 1.01 .95 .89 .97 1.03
Gdf6
KLA  ATP  ATP+KLA
 NM_013526 growth differentiation factor 6 (Gdf6), mRNA [NM_013526] KLA .91 1.01 .99 1.02 .96 1.07 1.01
ATP .99 1.00 1.04 1.04 1.01 1.03 .98
KLA/ATP .98 .93 .98 .99 1.05 1.05 1.01
Gdf7
KLA  ATP  ATP+KLA
 NM_013527 growth differentiation factor 7 (Gdf7), mRNA [NM_013527] KLA .78 .75 .77 .90 .93 .92 .94
ATP .94 .95 1.01 .86 .92 .99 1.00
KLA/ATP .76 .73 .88 .82 .93 .86 .82
Gh
KLA  ATP  ATP+KLA
 NM_008117 growth hormone (Gh), mRNA [NM_008117] KLA 1.02 1.03 1.01 .98 .98 .94 .98
ATP .94 1.02 1.06 1.20 .99 .95 .96
KLA/ATP .97 1.03 1.03 1.09 .96 1.00 1.05
Ghr
KLA  ATP  ATP+KLA
 AK053579 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111P21 product:growth hormone receptor, full insert sequence. [AK053579] KLA 1.10 1.07 1.09 1.01 1.03 .96 1.02
ATP 1.04 1.01 1.06 .96 1.03 .96 1.02
KLA/ATP 1.08 1.15 1.15 1.04 1.02 1.07 1.03
Ghr
KLA  ATP  ATP+KLA
 NM_010284 growth hormone receptor (Ghr), transcript variant 1, mRNA [NM_010284] KLA 1.09 1.10 1.29 1.31 1.23 1.09 .97
ATP 1.00 1.02 1.03 1.02 .93 .96 .97
KLA/ATP 1.17 1.20 1.15 1.15 1.07 .96 .96
Hgf
KLA  ATP  ATP+KLA
 AK033274 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030481P22 product:inferred: hepatocyte growth factor [AK033274] KLA 1.34 1.22 .96 .93 .82 .93 .87
ATP 1.64 2.45 3.30 1.89 .97 1.12 .90
KLA/ATP 1.49 2.50 3.96 1.88 1.07 1.00 .83
Hgf
KLA  ATP  ATP+KLA
 NM_010427 hepatocyte growth factor (Hgf), mRNA [NM_010427] KLA 1.11 1.18 1.30 1.20 1.08 .96 1.14
ATP 1.02 1.14 1.32 1.62 1.17 1.26 1.47
KLA/ATP 1.18 1.24 1.33 1.84 1.19 1.09 1.31
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifne1
KLA  ATP  ATP+KLA
 NM_177348 interferon epsilon 1 (Ifne1), mRNA [NM_177348] KLA .99 1.04 1.00 1.00 1.02 .96 .90
ATP .93 .96 1.00 1.06 .96 1.07 .96
KLA/ATP 1.07 1.01 1.02 1.01 .89 .95 1.04
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Ifnk
KLA  ATP  ATP+KLA
 NM_199157 interferon kappa (Ifnk), mRNA [NM_199157] KLA 1.04 1.03 1.05 1.06 1.04 1.05 1.04
ATP 1.04 1.00 .98 1.05 .98 1.09 1.03
KLA/ATP 1.10 1.03 1.01 1.02 .95 1.03 1.01
Il10
KLA  ATP  ATP+KLA
 NM_010548 interleukin 10 (Il10), mRNA [NM_010548] KLA 17.59 18.64 22.22 23.06 11.83 8.27 2.07
ATP 1.86 3.22 7.72 20.51 25.86 8.38 1.01
KLA/ATP 17.91 23.49 34.53 34.48 20.98 12.03 8.17
Il10ra
KLA  ATP  ATP+KLA
 NM_008348 interleukin 10 receptor, alpha (Il10ra), mRNA [NM_008348] KLA 4.92 4.49 5.29 3.79 4.00 3.02 1.77
ATP 1.15 1.13 1.19 1.16 2.95 1.73 .80
KLA/ATP 5.70 4.92 6.13 3.01 4.78 3.11 2.37
Il10rb
KLA  ATP  ATP+KLA
 AF440787 C57BL [AF440787] KLA .71 .67 .65 .81 1.20 1.50 1.07
ATP 1.03 1.04 1.01 1.12 .84 .85 1.52
KLA/ATP .67 .68 .70 .82 .92 1.23 1.83
Il10rb
KLA  ATP  ATP+KLA
 AK018347 12 days embryo female ovary cDNA, RIKEN full-length enriched library, clone:6620401D04 product:unclassifiable, full insert sequence. [AK018347] KLA .89 1.00 1.05 1.07 1.29 1.12 .96
ATP .91 .73 1.23 1.43 .98 1.06 .92
KLA/ATP .86 .83 1.13 1.41 1.24 1.11 1.13
Il11
KLA  ATP  ATP+KLA
 NM_008350 interleukin 11 (Il11), mRNA [NM_008350] KLA .98 1.04 1.03 1.03 .96 1.01 1.02
ATP .94 .97 1.07 1.15 1.18 1.19 1.09
KLA/ATP 1.03 1.10 1.06 1.29 1.72 2.17 1.23
Il11ra1
KLA  ATP  ATP+KLA
 NM_010549 interleukin 11 receptor, alpha chain 1 (Il11ra1), mRNA [NM_010549] KLA .65 .63 .59 .66 .66 .75 .57
ATP .93 .86 1.11 1.02 1.65 2.34 1.14
KLA/ATP .56 .66 .88 .71 1.75 2.07 1.00
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il12rb1
KLA  ATP  ATP+KLA
 NM_008353 interleukin 12 receptor, beta 1 (Il12rb1), mRNA [NM_008353] KLA 5.45 6.11 10.84 11.19 11.06 13.02 9.19
ATP .93 1.01 1.29 1.30 1.15 3.27 10.16
KLA/ATP 5.71 6.16 7.00 5.38 5.70 5.81 11.01
Il12rb2
KLA  ATP  ATP+KLA
 NM_008354 interleukin 12 receptor, beta 2 (Il12rb2), mRNA [NM_008354] KLA .93 1.02 1.05 1.02 .81 .77 .65
ATP 1.12 1.17 1.00 1.10 .87 .75 .57
KLA/ATP 1.08 1.13 .84 1.04 .81 .80 .58
Il13
KLA  ATP  ATP+KLA
 NM_008355 interleukin 13 (Il13), mRNA [NM_008355] KLA 1.08 1.05 .98 1.10 1.01 1.03 1.02
ATP 1.00 .98 1.08 .98 .99 1.05 .97
KLA/ATP .96 .96 1.09 1.02 1.04 1.01 .97
Il13ra1
KLA  ATP  ATP+KLA
 NM_133990 interleukin 13 receptor, alpha 1 (Il13ra1), mRNA [NM_133990] KLA 11.37 13.15 17.62 17.27 15.33 10.98 1.55
ATP .99 1.05 1.34 1.48 1.33 3.42 5.64
KLA/ATP 13.26 14.21 15.25 14.77 11.07 9.20 10.89
Il15
KLA  ATP  ATP+KLA
 AB022307 mRNA for shorter isoform of interleukin 15, partial cds. [AB022307] KLA 13.11 12.14 12.05 8.72 4.50 3.62 1.70
ATP 1.04 1.05 1.94 1.72 1.74 3.48 1.69
KLA/ATP 13.23 13.71 21.01 21.43 21.51 10.85 4.55
Il15
KLA  ATP  ATP+KLA
 NM_008357 interleukin 15 (Il15), mRNA [NM_008357] KLA 28.44 24.75 23.34 20.83 11.02 7.27 2.51
ATP 1.00 .96 1.22 1.21 1.24 4.27 1.85
KLA/ATP 24.24 23.93 33.47 31.76 21.73 10.79 11.23
Il15ra
KLA  ATP  ATP+KLA
 NM_008358 interleukin 15 receptor, alpha chain (Il15ra), transcript variant 1, mRNA [NM_008358] KLA 8.74 9.57 10.15 8.79 7.56 7.63 3.77
ATP .96 .93 1.02 1.07 2.02 3.73 1.46
KLA/ATP 9.56 10.41 10.94 10.62 11.08 9.82 8.07
Il17a
KLA  ATP  ATP+KLA
 NM_010552 interleukin 17A (Il17a), mRNA [NM_010552] KLA 1.25 1.09 .98 1.02 1.00 .93 .94
ATP 1.01 1.06 1.07 .97 .99 1.09 1.04
KLA/ATP .94 1.00 .99 .99 .99 .84 1.02
Il17b
KLA  ATP  ATP+KLA
 NM_019508 interleukin 17B (Il17b), mRNA [NM_019508] KLA 1.01 .93 1.02 .96 .99 1.03 1.01
ATP 1.04 1.01 .99 .96 1.02 .97 1.01
KLA/ATP 1.00 1.06 1.01 1.00 1.00 .95 .96
Il17ra
KLA  ATP  ATP+KLA
 NM_008359 interleukin 17 receptor A (Il17ra), mRNA [NM_008359] KLA 1.56 1.71 1.94 2.76 3.40 2.61 1.63
ATP .93 .93 .98 3.11 7.40 5.35 1.19
KLA/ATP 1.65 1.96 3.14 5.65 8.72 6.61 2.24
Il17rb
KLA  ATP  ATP+KLA
 AF208109 IL-17 receptor homolog short isoform precursor (Evi27) mRNA, complete cds [AF208109] KLA .92 .97 .98 1.00 .99 1.02 .95
ATP 1.08 .99 .97 .89 1.02 .99 .95
KLA/ATP 1.00 1.02 1.05 .97 .98 .95 .91
Il17rb
KLA  ATP  ATP+KLA
 NM_019583 interleukin 17 receptor B (Il17rb), mRNA [NM_019583] KLA 1.06 1.01 .99 1.00 1.02 1.00 .96
ATP .92 1.03 1.01 .94 .97 1.05 1.06
KLA/ATP .96 .96 1.05 1.03 .94 .95 1.01
Il18
KLA  ATP  ATP+KLA
 NM_008360 interleukin 18 (Il18), mRNA [NM_008360] KLA 12.14 11.96 12.28 12.96 12.23 7.84 2.40
ATP 1.06 .96 1.13 1.04 .92 1.67 2.29
KLA/ATP 11.55 11.63 13.03 9.98 9.08 6.50 6.72
Il18r1
KLA  ATP  ATP+KLA
 NM_008365 interleukin 18 receptor 1 (Il18r1), mRNA [NM_008365] KLA .95 1.02 .95 1.03 .98 1.00 .98
ATP .97 1.02 .96 .93 .94 .99 1.08
KLA/ATP .97 .97 .97 .99 .91 .91 .94
Il18rap
KLA  ATP  ATP+KLA
 AK053176 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030025K24 product:interleukin 18 receptor accessory protein, full insert sequence. [AK053176] KLA .98 1.01 1.01 1.00 1.02 1.02 .96
ATP 1.04 1.01 .94 1.02 .91 1.06 1.02
KLA/ATP 1.00 1.11 .99 .94 1.01 .90 .95
Il18rap
KLA  ATP  ATP+KLA
 NM_010553 interleukin 18 receptor accessory protein (Il18rap), mRNA [NM_010553] KLA 1.82 1.84 2.28 1.68 1.31 .84 .76
ATP 1.07 1.13 1.03 .95 .87 .80 .77
KLA/ATP 1.92 2.15 1.60 1.34 1.02 .93 .82
Il19
KLA  ATP  ATP+KLA
 NM_001009940 interleukin 19 (Il19), mRNA [NM_001009940] KLA 6.74 6.59 7.45 8.17 6.81 3.16 1.40
ATP 1.09 1.01 1.26 2.37 3.94 10.69 1.40
KLA/ATP 6.42 6.47 6.34 7.69 7.34 8.99 4.83
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il1r1
KLA  ATP  ATP+KLA
 NM_008362 interleukin 1 receptor, type I (Il1r1), transcript variant 1, mRNA [NM_008362] KLA 1.20 1.08 1.22 1.52 2.19 2.32 1.61
ATP 1.10 .96 1.18 1.56 8.14 9.56 7.54
KLA/ATP 1.22 1.13 1.37 1.85 4.54 6.85 8.96
Il1r2
KLA  ATP  ATP+KLA
 NM_010555 interleukin 1 receptor, type II (Il1r2), mRNA [NM_010555] KLA 1.05 1.03 1.08 1.13 1.09 1.08 1.14
ATP 1.03 1.08 1.30 1.68 1.38 1.10 1.19
KLA/ATP 1.08 1.14 1.17 1.27 1.10 1.11 2.03
Il1rap
KLA  ATP  ATP+KLA
 AK032620 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430709H04 product:unclassifiable, full insert sequence [AK032620] KLA 1.05 .98 1.07 .95 .98 .95 .92
ATP .95 .98 1.05 1.01 .94 1.01 1.02
KLA/ATP .96 1.07 1.07 1.10 .99 1.03 1.01
Il1rap
KLA  ATP  ATP+KLA
 AK045686 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230304B05 product:interleukin 1 receptor accessory protein, full insert sequence [AK045686] KLA 2.25 2.43 2.55 2.32 2.32 1.35 .81
ATP 1.13 1.31 1.25 1.28 1.04 1.28 .75
KLA/ATP 2.49 2.48 1.87 2.62 1.83 1.50 .77
Il1rap
KLA  ATP  ATP+KLA
 NM_008364 interleukin 1 receptor accessory protein (Il1rap), transcript variant 1, mRNA [NM_008364] KLA 1.11 1.16 1.17 1.15 1.11 .97 .97
ATP 1.02 1.12 1.07 1.03 1.01 .98 .84
KLA/ATP 1.20 1.19 1.07 1.10 .98 1.06 .89
Il1rap
KLA  ATP  ATP+KLA
 NM_134103 interleukin 1 receptor accessory protein (Il1rap), transcript variant 2, mRNA [NM_134103] KLA 1.42 1.42 1.46 1.39 1.40 1.14 .90
ATP 1.10 1.16 1.22 1.04 .98 .81 .79
KLA/ATP 1.45 1.53 1.33 1.33 1.08 .98 .75
Il2
KLA  ATP  ATP+KLA
 NM_008366 interleukin 2 (Il2), mRNA [NM_008366] KLA .96 .97 .96 1.00 .97 .97 .99
ATP 1.04 1.02 1.00 1.03 .97 .98 .97
KLA/ATP 1.01 .98 .97 1.00 .97 .97 .96
Il20
KLA  ATP  ATP+KLA
 NM_021380 interleukin 20 (Il20), mRNA [NM_021380] KLA 1.02 1.03 1.00 1.06 1.06 .94 .88
ATP 1.02 1.05 .88 .99 1.02 1.06 1.13
KLA/ATP .97 .94 1.05 1.07 1.11 1.03 1.07
Il20ra
KLA  ATP  ATP+KLA
 NM_172786 interleukin 20 receptor, alpha (Il20ra), mRNA [NM_172786] KLA 1.02 .95 .93 1.00 .97 .98 .98
ATP 1.02 .93 1.00 1.04 .97 1.03 1.01
KLA/ATP .99 .96 .88 .94 1.03 1.06 .93
Il20rb
KLA  ATP  ATP+KLA
 AK076401 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732496H22 product:unclassifiable, full insert sequence [AK076401] KLA 2.19 1.90 1.55 1.56 1.92 1.41 1.23
ATP 1.21 1.28 1.40 1.68 3.23 2.30 1.11
KLA/ATP 2.99 4.07 3.95 2.16 3.27 3.03 2.09
Il20rb
KLA  ATP  ATP+KLA
 NM_001033543 interleukin 20 receptor beta (Il20rb), mRNA [NM_001033543] KLA 7.23 6.19 4.74 4.77 3.85 3.07 2.30
ATP .95 .81 2.35 3.50 4.35 6.84 1.75
KLA/ATP 6.38 6.46 11.52 10.85 7.62 8.70 6.09
Il21
KLA  ATP  ATP+KLA
 NM_021782 interleukin 21 (Il21), mRNA [NM_021782] KLA .96 .99 1.01 1.01 .99 .99 .97
ATP .94 .95 1.07 .93 1.02 .96 1.00
KLA/ATP .95 .97 .98 1.04 1.01 1.06 1.00
Il21r
KLA  ATP  ATP+KLA
 NM_021887 interleukin 21 receptor (Il21r), mRNA [NM_021887] KLA .72 .87 1.22 1.88 2.63 3.16 1.00
ATP 1.01 .87 .81 .73 .82 3.86 3.67
KLA/ATP .76 .76 .97 .96 3.46 5.23 3.39
Il22
KLA  ATP  ATP+KLA
 NM_016971 interleukin 22 (Il22), mRNA [NM_016971] KLA .98 .98 .98 1.00 1.01 1.07 .98
ATP 1.03 1.03 .99 .99 1.01 .96 .99
KLA/ATP .94 1.05 1.00 1.00 .97 1.08 .96
Il22ra1
KLA  ATP  ATP+KLA
 NM_178257 interleukin 22 receptor, alpha 1 (Il22ra1), mRNA [NM_178257] KLA 1.04 .96 1.04 .99 1.01 1.01 .97
ATP .91 1.01 1.00 .99 .99 1.03 .98
KLA/ATP 1.04 1.02 1.00 1.00 .95 .94 .96
Il22ra2
KLA  ATP  ATP+KLA
 NM_178258 interleukin 22 receptor, alpha 2 (Il22ra2), mRNA [NM_178258] KLA .99 .92 1.03 1.04 1.02 1.05 1.01
ATP 1.06 1.00 1.00 1.09 1.01 .99 1.00
KLA/ATP .98 1.09 1.05 1.02 1.05 1.03 .99
Il23a
KLA  ATP  ATP+KLA
 NM_031252 interleukin 23, alpha subunit p19 (Il23a), mRNA [NM_031252] KLA 1.36 1.46 1.33 1.20 1.05 1.04 1.02
ATP .99 1.01 1.06 1.36 1.25 1.07 1.02
KLA/ATP 1.52 1.62 1.48 1.60 1.23 1.12 1.07
Il23r
KLA  ATP  ATP+KLA
 NM_144548 interleukin 23 receptor (Il23r), mRNA [NM_144548] KLA 1.40 1.33 1.51 1.62 2.19 3.40 4.65
ATP 1.10 1.03 1.01 .98 .98 1.06 1.08
KLA/ATP 1.26 1.45 1.38 1.38 1.23 1.38 4.41
Il24
KLA  ATP  ATP+KLA
 NM_053095 interleukin 24 (Il24), mRNA [NM_053095] KLA 1.00 .99 1.06 1.03 1.02 1.03 .98
ATP 1.02 .98 1.08 1.01 1.05 1.04 .98
KLA/ATP .96 1.04 1.08 1.00 1.05 .97 .97
Il25
KLA  ATP  ATP+KLA
 NM_080729 interleukin 25 (Il25), mRNA [NM_080729] KLA 1.02 1.01 1.06 .91 1.03 1.03 1.01
ATP 1.02 .99 1.05 1.18 1.08 .96 1.04
KLA/ATP 1.01 .90 .96 1.07 .95 1.06 1.05
Il28b
KLA  ATP  ATP+KLA
 NM_177396 interleukin 28B (Il28b), mRNA [NM_177396] KLA 1.05 1.07 .95 1.00 .99 .96 .90
ATP .93 .99 1.01 .92 .94 1.08 1.00
KLA/ATP .97 .97 1.12 1.02 .91 .96 .95
Il28ra
KLA  ATP  ATP+KLA
 NM_174851 interleukin 28 receptor alpha (Il28ra), mRNA [NM_174851] KLA 1.00 .85 .97 .95 .99 .98 .99
ATP 1.05 .99 1.06 .94 1.02 .99 1.09
KLA/ATP .90 1.01 1.02 .89 .99 .99 1.07
Il2ra
KLA  ATP  ATP+KLA
 AF054581 interleukin 2 receptor mRNA, 3UTR, partial sequence. [AF054581] KLA 1.76 2.05 2.73 2.46 3.58 2.68 1.13
ATP .99 .99 1.00 1.09 1.13 1.14 1.03
KLA/ATP 1.93 2.11 1.32 2.27 1.87 2.13 1.37
Il2ra
KLA  ATP  ATP+KLA
 NM_008367 interleukin 2 receptor, alpha chain (Il2ra), mRNA [NM_008367] KLA 1.33 1.29 1.46 1.43 1.82 1.57 1.15
ATP 1.02 1.03 1.01 1.02 1.01 1.12 1.05
KLA/ATP 1.30 1.46 1.36 1.41 1.22 1.47 1.66
Il2rb
KLA  ATP  ATP+KLA
 NM_008368 interleukin 2 receptor, beta chain (Il2rb), mRNA [NM_008368] KLA .92 1.00 1.00 1.00 .91 .98 1.09
ATP 1.02 .98 1.00 .95 1.02 1.04 1.04
KLA/ATP 1.03 .98 1.01 .99 .94 1.13 1.00
Il2rg
KLA  ATP  ATP+KLA
 NM_013563 interleukin 2 receptor, gamma chain (Il2rg), mRNA [NM_013563] KLA 2.97 2.92 3.73 3.39 4.04 3.45 4.83
ATP 1.25 1.41 1.04 1.82 1.48 1.12 2.89
KLA/ATP 3.65 4.34 2.42 4.70 2.62 2.54 5.15
Il3
KLA  ATP  ATP+KLA
 NM_010556 interleukin 3 (Il3), mRNA [NM_010556] KLA 1.05 .94 1.01 .99 1.03 1.07 .95
ATP .95 1.03 1.03 .98 .98 .97 .96
KLA/ATP 1.02 1.03 1.02 .94 .97 1.02 1.04
Il3ra
KLA  ATP  ATP+KLA
 NM_008369 interleukin 3 receptor, alpha chain (Il3ra), mRNA [NM_008369] KLA 1.23 1.35 1.52 1.31 1.38 1.42 1.35
ATP 1.04 1.20 1.11 1.42 1.18 .94 .77
KLA/ATP 1.33 1.45 1.45 1.69 1.25 1.22 1.32
Il4
KLA  ATP  ATP+KLA
 NM_021283 interleukin 4 (Il4), mRNA [NM_021283] KLA .94 .95 .91 .94 .91 .94 1.07
ATP 1.02 1.06 1.05 1.22 1.12 1.10 1.26
KLA/ATP .92 .96 .93 1.08 .98 1.03 1.18
Il4ra
KLA  ATP  ATP+KLA
 NM_001008700 interleukin 4 receptor, alpha (Il4ra), mRNA [NM_001008700] KLA 4.65 4.81 8.69 11.26 14.81 9.10 1.64
ATP .97 .88 .64 .58 3.81 9.28 4.93
KLA/ATP 4.86 4.84 5.43 3.60 4.37 10.35 6.16
Il5
KLA  ATP  ATP+KLA
 NM_010558 interleukin 5 (Il5), mRNA [NM_010558] KLA 1.10 1.11 1.10 .98 1.01 .98 .97
ATP .94 1.04 1.08 .92 .97 1.02 1.03
KLA/ATP .98 .92 1.12 1.03 1.02 1.00 1.03
Il5ra
KLA  ATP  ATP+KLA
 NM_008370 interleukin 5 receptor, alpha (Il5ra), mRNA [NM_008370] KLA 1.09 1.05 1.10 1.06 .98 1.00 .97
ATP .95 1.02 .99 .97 .99 1.01 .99
KLA/ATP .99 1.06 1.09 1.00 1.03 .99 1.07
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Il6ra
KLA  ATP  ATP+KLA
 NM_010559 interleukin 6 receptor, alpha (Il6ra), mRNA [NM_010559] KLA .50 .53 .65 .86 1.36 1.72 1.00
ATP .97 1.20 1.17 1.25 .74 .67 .95
KLA/ATP .50 .60 .61 .64 .59 .76 1.14
Il6st
KLA  ATP  ATP+KLA
 NM_010560 interleukin 6 signal transducer (Il6st), mRNA [NM_010560] KLA .31 .30 .36 .34 .33 .35 .42
ATP 1.16 1.12 .82 .62 1.58 1.85 1.25
KLA/ATP .38 .37 .30 .27 .78 1.56 .98
Il7
KLA  ATP  ATP+KLA
 AK041403 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630007F02 product:interleukin 7, full insert sequence [AK041403] KLA .96 .96 .97 1.00 1.01 .97 1.08
ATP 1.05 1.00 .98 .99 .94 .98 .95
KLA/ATP 1.05 1.05 .96 .99 .94 .99 .92
Il7
KLA  ATP  ATP+KLA
 NM_008371 interleukin 7 (Il7), mRNA [NM_008371] KLA 1.29 1.38 1.32 1.39 1.24 1.40 1.26
ATP 1.01 .98 1.02 .98 1.03 1.10 1.08
KLA/ATP 1.22 1.31 1.17 1.20 1.04 1.21 1.32
Il7r
KLA  ATP  ATP+KLA
 AK041838 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630041A17 product:interleukin 7 receptor, full insert sequence. [AK041838] KLA .90 1.04 .92 .95 .90 1.05 .99
ATP .97 1.01 1.11 1.04 1.06 1.33 2.92
KLA/ATP .98 .97 .91 1.10 1.06 1.20 1.57
Il7r
KLA  ATP  ATP+KLA
 NM_008372 interleukin 7 receptor (Il7r), mRNA [NM_008372] KLA .42 .40 .37 .41 .36 .60 .73
ATP 1.02 1.01 1.23 1.13 1.72 2.94 7.90
KLA/ATP .40 .41 .53 .58 1.00 2.18 4.13
Il8ra
KLA  ATP  ATP+KLA
 NM_178241 interleukin 8 receptor, alpha (Il8ra), mRNA [NM_178241] KLA .96 1.09 1.01 1.02 .92 .93 .95
ATP .95 .99 .88 .99 1.02 1.02 .96
KLA/ATP 1.01 1.03 .92 .99 1.02 1.02 1.00
Il8rb
KLA  ATP  ATP+KLA
 NM_009909 interleukin 8 receptor, beta (Il8rb), mRNA [NM_009909] KLA 1.05 1.01 1.06 .98 1.06 1.06 .85
ATP .98 .96 .99 .94 .98 .96 1.05
KLA/ATP 1.01 .93 1.04 .92 .98 .98 .99
Il9
KLA  ATP  ATP+KLA
 NM_008373 interleukin 9 (Il9), mRNA [NM_008373] KLA .97 1.02 1.06 1.03 1.04 1.02 1.05
ATP .98 .93 .98 1.03 1.02 1.04 .96
KLA/ATP 1.01 1.00 1.00 1.06 1.06 1.04 1.07
Il9r
KLA  ATP  ATP+KLA
 NM_008374 interleukin 9 receptor (Il9r), mRNA [NM_008374] KLA 1.01 1.02 1.01 1.02 1.01 1.01 .94
ATP .97 1.03 1.01 .94 .98 1.05 1.02
KLA/ATP 1.02 .95 1.01 1.03 1.01 .95 1.04
Inhba
KLA  ATP  ATP+KLA
 NM_008380 inhibin beta-A (Inhba), mRNA [NM_008380] KLA 7.13 7.30 8.51 8.11 5.73 5.18 5.94
ATP 1.03 1.23 3.72 7.04 13.27 17.63 11.55
KLA/ATP 6.97 10.73 20.43 21.90 23.12 20.33 20.24
Inhbb
KLA  ATP  ATP+KLA
 NM_008381 inhibin beta-B (Inhbb), mRNA [NM_008381] KLA 1.13 1.17 1.11 1.13 1.04 .98 .97
ATP 1.00 1.02 1.01 1.00 1.00 .97 1.00
KLA/ATP 1.22 1.23 1.24 1.07 1.05 1.00 .96
Inhbc
KLA  ATP  ATP+KLA
 NM_010565 inhibin beta-C (Inhbc), mRNA [NM_010565] KLA 1.01 .97 1.01 .99 .94 .96 .99
ATP 1.01 1.02 .95 .99 .93 .97 .96
KLA/ATP .91 .98 .98 .95 .94 .99 .92
Inhbe
KLA  ATP  ATP+KLA
 NM_008382 inhibin beta E (Inhbe), mRNA [NM_008382] KLA .97 1.02 1.12 1.15 1.03 1.06 1.03
ATP 1.03 .99 1.09 1.10 1.03 1.16 .73
KLA/ATP 1.08 1.07 1.13 1.07 1.08 1.04 1.05
Kdr
KLA  ATP  ATP+KLA
 AK054510 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330034B14 product:kinase insert domain protein receptor, full insert sequence. [AK054510] KLA 1.00 1.00 .98 1.03 1.02 1.00 .99
ATP .99 1.00 1.00 1.02 1.00 1.00 1.00
KLA/ATP 1.01 1.02 1.03 1.02 .98 1.00 1.01
Kdr
KLA  ATP  ATP+KLA
 NM_010612 kinase insert domain protein receptor (Kdr), mRNA [NM_010612] KLA 7.30 7.28 6.48 6.79 5.97 6.18 2.71
ATP 1.00 .84 1.06 1.14 3.62 3.10 7.15
KLA/ATP 6.62 7.17 7.12 6.48 14.11 12.63 11.01
Kit
KLA  ATP  ATP+KLA
 Y00864 gb|Mouse c-kit mRNA. [Y00864] KLA .88 .86 .83 .76 .75 .73 .87
ATP 1.06 1.07 1.03 1.04 3.95 1.93 1.25
KLA/ATP .87 .87 .89 .89 1.06 1.08 .91
Kitl
KLA  ATP  ATP+KLA
 NM_013598 kit ligand (Kitl), mRNA [NM_013598] KLA .49 .46 .43 .38 .23 .35 .46
ATP .89 .85 .79 .91 1.14 1.30 .86
KLA/ATP .48 .43 .49 .96 1.59 1.38 .95
Lep
KLA  ATP  ATP+KLA
 NM_008493 leptin (Lep), mRNA [NM_008493] KLA .99 1.00 1.00 .99 .99 .99 1.00
ATP 1.01 1.00 .98 1.01 1.01 .99 .98
KLA/ATP 1.01 1.02 1.01 .97 1.00 1.00 .99
Lepr
KLA  ATP  ATP+KLA
 NM_001122899 leptin receptor (Lepr), transcript variant 3, mRNA [NM_001122899] KLA .98 1.05 1.00 1.03 .98 1.01 1.10
ATP 1.07 .99 .98 1.06 1.08 1.02 1.02
KLA/ATP 1.07 1.03 .99 1.11 1.03 1.12 .98
Lepr
KLA  ATP  ATP+KLA
 NM_010704 leptin receptor (Lepr), transcript variant 2, mRNA [NM_010704] KLA 1.01 1.01 1.03 .99 1.01 1.02 .99
ATP .98 1.00 1.02 1.02 1.02 1.02 1.01
KLA/ATP 1.00 1.00 1.02 1.03 1.00 1.01 .98
Lifr
KLA  ATP  ATP+KLA
 NM_013584 leukemia inhibitory factor receptor (Lifr), transcript variant 1, mRNA [NM_013584] KLA .75 .76 .74 .72 .58 .43 .36
ATP .96 .90 .79 .71 .65 .69 .36
KLA/ATP .73 .69 .72 .68 .65 .53 .36
Lta
KLA  ATP  ATP+KLA
 NM_010735 lymphotoxin A (Lta), mRNA [NM_010735] KLA 1.95 2.18 2.41 2.18 2.50 2.26 1.79
ATP 1.01 1.00 1.10 1.55 1.24 1.09 1.07
KLA/ATP 2.16 2.23 1.85 2.11 1.60 1.31 1.33
Ltb
KLA  ATP  ATP+KLA
 NM_008518 lymphotoxin B (Ltb), mRNA [NM_008518] KLA 2.41 2.52 2.49 3.05 3.54 4.63 1.94
ATP 1.00 .92 1.28 1.57 1.77 1.64 .98
KLA/ATP 2.22 2.68 2.81 3.15 4.88 4.53 2.01
Ltbr
KLA  ATP  ATP+KLA
 NM_010736 lymphotoxin B receptor (Ltbr), mRNA [NM_010736] KLA .78 .77 .80 .95 1.08 1.39 1.36
ATP .94 .86 1.00 .83 .74 1.18 1.37
KLA/ATP .69 .71 .74 .68 .85 1.04 1.69
Met
KLA  ATP  ATP+KLA
 NM_008591 met proto-oncogene (Met), mRNA [NM_008591] KLA 3.56 3.71 3.68 3.79 4.24 5.89 6.95
ATP .98 .96 1.16 1.21 3.32 12.98 6.60
KLA/ATP 3.75 3.80 3.58 3.28 3.69 4.27 14.22
Mm.18927
0
KLA  ATP  ATP+KLA
 142353600 Unknown KLA .95 .97 .98 1.09 1.00 .99 1.05
ATP 1.04 .96 1.00 1.01 .97 .93 .97
KLA/ATP 1.04 1.06 1.08 1.01 1.04 .95 .91
Mm.19345
1
KLA  ATP  ATP+KLA
 141802044 Unknown KLA .67 .64 .57 .63 .57 .75 .54
ATP .88 .81 1.15 .97 1.46 2.27 1.19
KLA/ATP .55 .60 .84 .67 1.75 2.01 .95
Mm.23446
6
KLA  ATP  ATP+KLA
 87299639 Unknown KLA .92 1.02 1.03 1.00 1.00 1.10 1.07
ATP 1.03 1.01 1.12 .94 1.03 .91 1.01
KLA/ATP .98 1.00 1.03 1.05 1.04 1.11 1.03
Mm.24004
7
KLA  ATP  ATP+KLA
 118130430 Unknown KLA 1.09 1.07 1.01 1.00 1.04 1.05 .97
ATP .98 1.00 1.05 .97 1.05 1.02 1.05
KLA/ATP .98 1.04 1.16 1.06 1.06 .96 1.02
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.25366
4
KLA  ATP  ATP+KLA
 6680422 Unknown KLA 1.10 1.06 1.08 1.06 1.12 1.04 1.11
ATP 1.02 .98 .99 1.02 .98 1.09 .95
KLA/ATP 1.02 1.09 1.09 1.10 1.04 1.10 1.12
Mm.27492
7
KLA  ATP  ATP+KLA
 157012006 Unknown KLA 1.53 1.40 2.02 2.77 2.61 2.39 1.11
ATP 1.08 1.25 2.14 3.10 7.35 20.10 23.05
KLA/ATP 1.38 1.67 2.98 4.34 6.46 11.28 28.93
Mm.28722
8
KLA  ATP  ATP+KLA
 160707972 Unknown KLA 1.08 1.08 1.05 1.13 1.29 1.37 1.09
ATP 1.04 .96 1.15 .83 .88 1.18 1.09
KLA/ATP 1.06 .86 1.30 1.05 1.19 1.00 1.19
Mm.2932
KLA  ATP  ATP+KLA
 116268120 Unknown KLA 1.74 1.87 2.38 2.24 2.14 1.97 1.66
ATP 1.06 .97 1.25 2.61 3.26 3.23 1.78
KLA/ATP 2.10 2.32 3.52 5.43 5.89 6.74 4.66
Mm.30211
KLA  ATP  ATP+KLA
 119392097 Unknown KLA 1.01 1.08 .87 .90 .84 .79 .76
ATP .90 1.00 1.29 1.51 1.34 1.32 1.26
KLA/ATP .94 1.04 1.10 1.33 1.09 1.34 1.34
Mm.35771
KLA  ATP  ATP+KLA
 141802359 Unknown KLA 1.27 1.19 1.20 1.42 1.30 1.42 1.36
ATP .92 .84 1.11 1.08 .99 1.01 .91
KLA/ATP 1.09 1.12 1.37 1.35 1.32 1.25 1.23
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.384
KLA  ATP  ATP+KLA
 197333823 Unknown KLA 1.04 1.03 .99 1.02 1.00 .91 .99
ATP 1.03 .99 1.02 .97 1.00 .91 .97
KLA/ATP 1.03 1.10 1.01 1.01 1.01 .87 1.00
Mm.4364
KLA  ATP  ATP+KLA
 37591174 Unknown KLA .27 .24 .28 .30 .24 .30 .33
ATP .97 .90 .94 .52 1.37 2.32 1.14
KLA/ATP .27 .24 .29 .20 .77 1.62 .76
Mm.47283
8
KLA  ATP  ATP+KLA
 158428111 Unknown KLA 6.79 5.95 4.54 4.42 3.72 2.98 2.26
ATP .97 .84 2.21 3.33 4.29 6.69 1.73
KLA/ATP 6.49 6.68 10.69 10.34 7.43 8.15 5.85
Mm.4744
KLA  ATP  ATP+KLA
 6679980 Unknown KLA 1.08 1.04 1.02 1.05 .98 1.02 .72
ATP 1.02 1.12 .98 1.06 1.02 1.00 1.00
KLA/ATP .96 1.00 1.11 1.04 .99 .97 1.01
Mm.4864
KLA  ATP  ATP+KLA
 171846241 Unknown KLA .97 1.10 1.04 1.02 1.04 1.09 1.03
ATP 1.03 .96 1.07 1.02 .97 1.05 1.12
KLA/ATP 1.05 .97 .93 1.07 1.02 1.05 1.03
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Mm.874
KLA  ATP  ATP+KLA
 6754317 Unknown KLA 24.98 24.87 26.43 39.61 12.88 8.64 1.63
ATP 1.97 3.50 11.05 28.47 38.30 10.44 .65
KLA/ATP 23.45 29.37 58.52 51.77 30.64 14.61 8.63
Mm.8983
KLA  ATP  ATP+KLA
 77627742 Unknown KLA .89 .94 .87 .83 .73 .60 .41
ATP 1.02 1.06 1.14 1.28 1.11 .76 .55
KLA/ATP 1.00 .98 1.03 1.19 1.01 .70 .54
Mpl
KLA  ATP  ATP+KLA
 NM_010823 myeloproliferative leukemia virus oncogene (Mpl), transcript variant 2, mRNA [NM_010823] KLA 1.07 1.06 1.16 1.13 1.14 .97 1.11
ATP .97 1.00 1.03 1.13 1.14 1.00 1.02
KLA/ATP 1.14 1.21 1.13 1.02 1.07 1.05 1.07
Ngfr
KLA  ATP  ATP+KLA
 NM_033217 nerve growth factor receptor (TNFR superfamily, member 16) (Ngfr), mRNA [NM_033217] KLA 1.06 1.08 1.08 1.06 1.07 1.09 1.08
ATP .99 1.01 1.06 1.03 1.01 1.04 1.04
KLA/ATP 1.04 1.07 1.08 1.06 1.05 1.04 1.11
Osm
KLA  ATP  ATP+KLA
 NM_001013365 oncostatin M (Osm), mRNA [NM_001013365] KLA 1.56 1.46 1.46 2.02 1.99 1.68 1.47
ATP 2.40 4.29 10.76 14.66 10.66 9.53 2.21
KLA/ATP 1.94 3.15 10.63 13.85 12.20 11.12 5.30
Osmr
KLA  ATP  ATP+KLA
 NM_011019 oncostatin M receptor (Osmr), mRNA [NM_011019] KLA 1.18 1.26 1.23 1.16 1.13 1.08 1.03
ATP 1.02 1.00 1.04 1.04 1.10 1.07 1.04
KLA/ATP 1.21 1.17 1.17 1.14 1.19 1.10 1.08
Pdgfa
KLA  ATP  ATP+KLA
 NM_008808 platelet derived growth factor, alpha (Pdgfa), mRNA [NM_008808] KLA .63 .56 .42 .34 .31 .33 .52
ATP .89 .80 .69 1.23 5.97 3.99 2.73
KLA/ATP .64 .53 .43 .77 3.48 3.78 2.37
Pdgfb
KLA  ATP  ATP+KLA
 NM_011057 platelet derived growth factor, B polypeptide (Pdgfb), mRNA [NM_011057] KLA .45 .43 .38 .46 .69 .48 .58
ATP .94 .95 .66 .74 .67 .77 1.06
KLA/ATP .43 .43 .37 .39 .52 .55 1.64
Pdgfc
KLA  ATP  ATP+KLA
 AK081347 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130008P20 product:platelet-derived growth factor, C polypeptide, full insert sequence. [AK081347] KLA .93 1.07 1.00 1.03 .93 .95 .98
ATP 1.05 1.04 .94 1.02 1.04 1.00 1.05
KLA/ATP 1.06 1.02 .99 .96 .99 1.05 1.01
Pdgfc
KLA  ATP  ATP+KLA
 NM_019971 platelet-derived growth factor, C polypeptide (Pdgfc), mRNA [NM_019971] KLA 1.56 1.52 1.84 2.08 1.83 1.33 .79
ATP .98 .91 .86 .91 .78 1.43 3.28
KLA/ATP 1.45 1.50 1.25 1.73 1.99 1.56 1.12
Pdgfd
KLA  ATP  ATP+KLA
 AK141551 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630020I23 product:platelet-derived growth factor, D polypeptide, full insert sequence [AK141551] KLA 1.07 1.01 1.06 .98 .94 1.00 1.00
ATP .98 .99 1.10 1.00 .96 1.00 .94
KLA/ATP 1.00 1.03 1.05 1.02 .94 .97 1.03
Pdgfd
KLA  ATP  ATP+KLA
 NM_027924 platelet-derived growth factor, D polypeptide (Pdgfd), mRNA [NM_027924] KLA .99 .93 .95 .97 1.00 .99 .95
ATP 1.01 .99 1.00 .93 1.05 1.04 1.06
KLA/ATP .91 .91 .96 .92 .92 .99 1.05
Pdgfra
KLA  ATP  ATP+KLA
 NM_011058 platelet derived growth factor receptor, alpha polypeptide (Pdgfra), transcript variant 1, mRNA [NM_011058] KLA 1.02 1.05 1.02 1.01 1.03 1.03 1.01
ATP 1.01 1.02 1.03 1.04 1.00 1.01 1.01
KLA/ATP 1.01 1.01 .99 1.03 1.02 1.03 1.01
Pdgfrb
KLA  ATP  ATP+KLA
 NM_008809 platelet derived growth factor receptor, beta polypeptide (Pdgfrb), mRNA [NM_008809] KLA 4.85 5.49 4.56 3.94 3.71 2.05 1.51
ATP .99 1.00 1.11 1.27 1.02 1.83 1.23
KLA/ATP 5.09 5.86 4.30 2.51 1.74 1.84 3.23
Pf4
KLA  ATP  ATP+KLA
 NM_019932 platelet factor 4 (Pf4), mRNA [NM_019932] KLA .98 .95 .88 .91 .77 .67 .29
ATP .95 .95 .97 .91 .87 1.79 9.27
KLA/ATP .91 .88 .91 .96 .75 .87 2.12
Ppbp
KLA  ATP  ATP+KLA
 NM_023785 pro-platelet basic protein (Ppbp), mRNA [NM_023785] KLA 1.17 1.27 1.09 1.25 1.09 1.02 .63
ATP .96 .89 1.10 1.14 1.55 10.17 70.24
KLA/ATP 1.16 1.04 1.19 1.26 1.27 3.28 10.96
Prl
KLA  ATP  ATP+KLA
 NM_011164 prolactin (Prl), mRNA [NM_011164] KLA 1.01 1.00 1.06 1.02 1.05 .96 .97
ATP .99 1.02 .97 .98 .97 .95 1.00
KLA/ATP 1.00 1.01 1.00 .97 .96 .87 .95
Prlr
KLA  ATP  ATP+KLA
 AK083198 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630026G18 product:unclassifiable, full insert sequence [AK083198] KLA .99 1.07 1.00 .95 1.01 .90 1.01
ATP 1.02 .94 .97 1.00 .97 .94 .96
KLA/ATP .98 .94 .96 .96 .99 1.07 1.02
Prlr
KLA  ATP  ATP+KLA
 AK087727 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330012C04 product:hypothetical protein, full insert sequence [AK087727] KLA 1.03 1.00 .99 1.01 1.02 1.04 .99
ATP 1.00 .95 1.13 1.06 .97 .98 1.04
KLA/ATP .97 1.01 .88 1.02 1.01 1.03 1.05
Prlr
KLA  ATP  ATP+KLA
 NM_011169 prolactin receptor (Prlr), mRNA [NM_011169] KLA .93 1.03 1.12 1.06 1.05 1.14 1.15
ATP .95 .99 1.11 1.13 1.06 1.19 1.18
KLA/ATP 1.02 1.01 1.05 1.10 1.10 1.21 1.07
Relt
KLA  ATP  ATP+KLA
 NM_177073 RELT tumor necrosis factor receptor (Relt), mRNA [NM_177073] KLA 1.01 .93 1.13 1.28 1.42 1.24 1.16
ATP 1.00 1.08 .99 1.35 .95 1.25 1.00
KLA/ATP .97 .94 .92 1.36 1.10 1.15 1.02
Tgfb1
KLA  ATP  ATP+KLA
 NM_011577 transforming growth factor, beta 1 (Tgfb1), mRNA [NM_011577] KLA .87 .89 .90 .70 .83 .77 1.12
ATP 1.20 1.41 .80 1.49 1.11 .93 .99
KLA/ATP 1.10 1.20 .53 1.05 .66 .85 .90
Tgfb2
KLA  ATP  ATP+KLA
 NM_009367 transforming growth factor, beta 2 (Tgfb2), mRNA [NM_009367] KLA 1.01 .91 .98 .98 .92 1.19 .96
ATP .99 1.03 1.00 1.02 .99 1.07 .93
KLA/ATP 1.02 .99 1.03 .98 1.04 1.06 .96
Tgfb3
KLA  ATP  ATP+KLA
 NM_009368 transforming growth factor, beta 3 (Tgfb3), mRNA [NM_009368] KLA .67 .64 .58 .56 .49 .52 .61
ATP .90 .92 1.33 1.08 .78 .65 .74
KLA/ATP .58 .60 .74 .61 .76 1.36 1.51
Tgfbr1
KLA  ATP  ATP+KLA
 NM_009370 transforming growth factor, beta receptor I (Tgfbr1), mRNA [NM_009370] KLA .73 .74 .59 .54 .52 .64 .84
ATP .99 1.12 .99 1.16 1.22 .84 .93
KLA/ATP .75 .78 .58 .64 .62 .59 .77
Tgfbr2
KLA  ATP  ATP+KLA
 AK090393 10 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:G630098D03 product:transforming growth factor, beta receptor II, full insert sequence. [AK090393] KLA .98 .89 1.00 .96 .94 1.00 .92
ATP .99 .99 .90 .94 .93 .96 1.02
KLA/ATP .92 .96 .98 .98 .98 .95 1.01
Tgfbr2
KLA  ATP  ATP+KLA
 NM_009371 transforming growth factor, beta receptor II (Tgfbr2), transcript variant 1, mRNA [NM_009371] KLA .55 .50 .58 .50 .52 .55 .44
ATP .98 .75 .50 .32 .41 .29 .50
KLA/ATP .59 .45 .32 .23 .31 .27 .25
Tgfbr2
KLA  ATP  ATP+KLA
 NM_029575 transforming growth factor, beta receptor II (Tgfbr2), transcript variant 2, mRNA [NM_029575] KLA .95 .93 .99 .95 .88 1.02 .82
ATP .87 .93 .84 .84 .74 .72 1.00
KLA/ATP .89 .85 .83 .85 .76 .80 .79
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfrsf10
b
KLA  ATP  ATP+KLA
 NM_020275 tumor necrosis factor receptor superfamily, member 10b (Tnfrsf10b), mRNA [NM_020275] KLA 1.29 1.24 1.23 1.14 .96 .88 .87
ATP .99 1.04 1.06 1.14 .95 1.10 1.15
KLA/ATP 1.26 1.26 1.21 1.23 1.03 .93 .93
Tnfrsf11
a
KLA  ATP  ATP+KLA
 NM_009399 tumor necrosis factor receptor superfamily, member 11a (Tnfrsf11a), mRNA [NM_009399] KLA 1.43 1.33 1.36 1.58 1.87 1.83 1.47
ATP 1.07 1.17 1.02 1.19 .95 .82 1.13
KLA/ATP 1.55 1.46 1.16 1.46 .79 .95 1.92
Tnfrsf11
b
KLA  ATP  ATP+KLA
 NM_008764 tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (Tnfrsf11b), mRNA [NM_008764] KLA 1.00 .98 .98 .98 1.02 .94 .90
ATP .99 .98 1.06 .97 .94 .99 .98
KLA/ATP .97 1.04 1.09 .94 .95 .92 1.01
Tnfrsf12
a
KLA  ATP  ATP+KLA
 NM_013749 tumor necrosis factor receptor superfamily, member 12a (Tnfrsf12a), mRNA [NM_013749] KLA 1.01 1.10 1.05 .89 .65 .56 .57
ATP .95 1.01 1.31 8.60 18.23 4.06 1.73
KLA/ATP 1.02 1.08 1.01 6.73 20.62 7.63 1.83
Tnfrsf13
b
KLA  ATP  ATP+KLA
 AK155178 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630206K19 product:tumor necrosis factor receptor superfamily, member 13b, full insert sequence [AK155178] KLA .49 .51 .50 .49 .55 .72 .66
ATP 1.01 1.08 1.16 1.27 .78 .28 .69
KLA/ATP .50 .54 .52 .54 .35 .28 .64
Tnfrsf13
b
KLA  ATP  ATP+KLA
 NM_021349 tumor necrosis factor receptor superfamily, member 13b (Tnfrsf13b), mRNA [NM_021349] KLA .85 .87 .83 .83 .89 .90 .90
ATP .96 .96 1.00 .98 .80 .75 .91
KLA/ATP .85 .87 .84 .88 .77 .84 .87
Tnfrsf13
c
KLA  ATP  ATP+KLA
 NM_028075 tumor necrosis factor receptor superfamily, member 13c (Tnfrsf13c), mRNA [NM_028075] KLA 1.05 1.04 1.05 1.01 1.05 1.00 .92
ATP 1.03 1.01 1.01 .99 1.04 1.03 1.04
KLA/ATP 1.05 1.07 1.10 1.04 1.02 .94 1.00
Tnfrsf14
KLA  ATP  ATP+KLA
 BF580152 gb|602099161F1 NCI_CGAP_Co24 Mus musculus cDNA clone IMAGE:4219095 5. [BF580152] KLA 2.85 3.00 3.94 4.08 5.37 6.26 4.71
ATP .86 1.02 1.02 1.14 1.06 1.63 2.89
KLA/ATP 2.65 2.78 2.71 2.68 2.18 2.24 4.36
Tnfrsf14
KLA  ATP  ATP+KLA
 NM_178931 tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (Tnfrsf14), mRNA [NM_178931] KLA 1.85 2.16 2.55 2.63 3.34 3.54 3.25
ATP .99 .95 1.15 1.16 .95 1.26 2.20
KLA/ATP 1.82 2.07 1.87 1.78 1.51 1.70 2.60
Tnfrsf17
KLA  ATP  ATP+KLA
 NM_011608 tumor necrosis factor receptor superfamily, member 17 (Tnfrsf17), mRNA [NM_011608] KLA .94 .89 .91 .93 .92 .80 .66
ATP .98 .94 1.02 .96 .94 .87 .71
KLA/ATP .97 .87 .94 .94 .96 .86 .66
Tnfrsf18
KLA  ATP  ATP+KLA
 NM_009400 tumor necrosis factor receptor superfamily, member 18 (Tnfrsf18), transcript variant 1, mRNA [NM_009400] KLA .84 .94 .77 .92 .90 .87 .77
ATP .94 .97 1.02 1.08 .99 1.00 .85
KLA/ATP .82 .84 .80 1.00 .99 1.06 .98
Tnfrsf19
KLA  ATP  ATP+KLA
 BC030062 tumor necrosis factor receptor superfamily, member 19, mRNA (cDNA clone MGC:40996 IMAGE:5256883), complete cds. [BC030062] KLA 1.02 .98 1.04 .98 .99 1.02 .99
ATP 1.03 1.13 1.00 .98 .96 .97 .95
KLA/ATP 1.04 .99 1.01 .99 1.00 .95 1.01
Tnfrsf19
KLA  ATP  ATP+KLA
 NM_013869 tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19), mRNA [NM_013869] KLA 1.03 1.00 1.01 1.06 1.06 .98 1.00
ATP 1.02 1.08 1.04 .97 1.00 1.08 1.05
KLA/ATP .99 .98 1.16 1.05 1.02 1.00 1.09
Tnfrsf1a
KLA  ATP  ATP+KLA
 NM_011609 tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a), mRNA [NM_011609] KLA 1.74 1.71 1.90 2.16 1.95 1.74 1.16
ATP .95 .83 .55 .41 .41 1.55 1.32
KLA/ATP 1.58 1.49 1.19 1.03 .98 2.02 2.10
Tnfrsf1b
KLA  ATP  ATP+KLA
 NM_011610 tumor necrosis factor receptor superfamily, member 1b (Tnfrsf1b), mRNA [NM_011610] KLA 9.07 9.05 8.93 10.89 10.14 11.61 6.74
ATP .98 .95 1.03 1.55 5.28 11.41 3.60
KLA/ATP 7.95 8.55 9.86 8.13 7.80 9.94 18.02
Tnfrsf21
KLA  ATP  ATP+KLA
 AK036984 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930033B06 product:tumor necrosis factor receptor superfamily, member 21, full insert sequence. [AK036984] KLA .81 .87 .78 .78 .84 .78 .81
ATP .85 .92 .74 .75 1.06 .96 .77
KLA/ATP .83 .81 .75 .79 .83 .88 .73
Tnfrsf21
KLA  ATP  ATP+KLA
 NM_178589 tumor necrosis factor receptor superfamily, member 21 (Tnfrsf21), mRNA [NM_178589] KLA .55 .52 .54 .54 .46 .47 .71
ATP .94 .86 .58 .45 .50 1.40 .94
KLA/ATP .54 .53 .49 .40 .43 .87 .66
Tnfrsf25
KLA  ATP  ATP+KLA
 NM_033042 tumor necrosis factor receptor superfamily, member 25 (Tnfrsf25), mRNA [NM_033042] KLA 1.14 1.10 1.03 1.06 1.01 1.04 1.03
ATP 1.00 .97 1.03 1.00 1.47 1.00 .91
KLA/ATP 1.07 1.12 1.11 1.12 2.01 1.09 .96
Tnfrsf4
KLA  ATP  ATP+KLA
 NM_011659 tumor necrosis factor receptor superfamily, member 4 (Tnfrsf4), mRNA [NM_011659] KLA 1.36 1.22 1.40 1.56 1.67 1.66 1.32
ATP .87 .59 .73 .84 1.47 1.19 .83
KLA/ATP 1.19 .96 1.10 1.11 1.93 1.30 1.12
Tnfrsf8
KLA  ATP  ATP+KLA
 NM_009401 tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8), mRNA [NM_009401] KLA 1.00 1.04 .98 1.05 1.05 1.01 1.03
ATP .94 .95 1.05 1.06 .96 .95 1.07
KLA/ATP 1.00 1.05 .99 .96 1.01 1.04 1.03
Tnfsf10
KLA  ATP  ATP+KLA
 NM_009425 tumor necrosis factor (ligand) superfamily, member 10 (Tnfsf10), mRNA [NM_009425] KLA 31.48 31.73 32.62 36.94 28.34 23.40 4.96
ATP 1.06 .93 1.28 1.24 1.07 2.74 3.33
KLA/ATP 28.07 30.23 43.53 33.98 27.97 18.71 17.43
Tnfsf11
KLA  ATP  ATP+KLA
 NM_011613 tumor necrosis factor (ligand) superfamily, member 11 (Tnfsf11), mRNA [NM_011613] KLA 1.00 1.00 1.08 .96 .97 1.01 .96
ATP 1.01 1.05 .97 .86 1.05 1.03 1.01
KLA/ATP 1.04 1.05 .99 1.04 1.01 1.02 .99
Tnfsf12
KLA  ATP  ATP+KLA
 NM_011614 tumor necrosis factor (ligand) superfamily, member 12 (Tnfsf12), mRNA [NM_011614] KLA .85 .81 .75 .82 .72 .72 .78
ATP .93 1.02 1.26 1.42 1.26 .99 1.22
KLA/ATP .78 .84 1.00 1.05 .98 .87 .81
Tnfsf12-
tnfsf13
KLA  ATP  ATP+KLA
 NM_001034097 tumor necrosis factor (ligand) superfamily, member 12-member 13 (Tnfsf12-tnfsf13), transcript variant 1, mRNA [NM_001034097] KLA .74 .74 .73 .64 .54 .42 .35
ATP .96 .99 1.06 1.25 1.11 .94 .61
KLA/ATP .76 .77 .76 .99 .86 .82 .55
Tnfsf13b
KLA  ATP  ATP+KLA
 ENSMUST00000033892 ens|Tumor necrosis factor ligand superfamily member 13B (B cell-activating factor) (BAFF) (CD257 antigen) [Contains: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]. [ KLA .95 .99 .93 .92 .94 .94 .92
ATP .90 .92 1.01 .91 .93 .95 .92
KLA/ATP .94 .89 1.17 1.03 .98 .93 .90
Tnfsf13b
KLA  ATP  ATP+KLA
 NM_033622 tumor necrosis factor (ligand) superfamily, member 13b (Tnfsf13b), mRNA [NM_033622] KLA .87 .87 .92 .79 .74 .80 1.17
ATP .97 .87 .83 .81 .79 .57 .38
KLA/ATP .91 .86 .87 .88 1.02 .89 .49
Tnfsf14
KLA  ATP  ATP+KLA
 NM_019418 tumor necrosis factor (ligand) superfamily, member 14 (Tnfsf14), mRNA [NM_019418] KLA .57 .66 .55 .82 .48 .29 .22
ATP 1.16 1.25 1.61 8.55 24.98 15.54 3.28
KLA/ATP .88 .70 .86 3.41 17.39 10.12 1.56
Tnfsf15
KLA  ATP  ATP+KLA
 NM_177371 tumor necrosis factor (ligand) superfamily, member 15 (Tnfsf15), mRNA [NM_177371] KLA 2.83 3.07 2.47 1.80 1.54 1.31 1.39
ATP 1.01 1.00 1.14 1.21 1.20 1.24 1.14
KLA/ATP 2.90 2.83 2.82 2.63 1.98 1.52 1.24
Tnfsf18
KLA  ATP  ATP+KLA
 NM_183391 tumor necrosis factor (ligand) superfamily, member 18 (Tnfsf18), mRNA [NM_183391] KLA 2.69 2.75 2.78 2.39 1.77 1.30 1.10
ATP 1.09 1.49 1.61 1.48 1.61 2.02 1.40
KLA/ATP 2.48 2.67 3.06 3.77 3.60 2.89 2.11
Tnfsf4
KLA  ATP  ATP+KLA
 NM_009452 tumor necrosis factor (ligand) superfamily, member 4 (Tnfsf4), mRNA [NM_009452] KLA 12.47 12.68 12.75 10.58 7.07 3.04 1.66
ATP 1.05 1.03 1.35 1.66 3.53 7.18 3.72
KLA/ATP 12.61 13.57 13.11 14.99 12.17 10.16 10.35
Tnfsf8
KLA  ATP  ATP+KLA
 NM_009403 tumor necrosis factor (ligand) superfamily, member 8 (Tnfsf8), mRNA [NM_009403] KLA 2.12 2.15 2.05 1.78 1.43 1.18 .74
ATP .99 .93 1.00 .92 .90 .99 .77
KLA/ATP 2.01 1.99 1.62 1.39 1.06 1.10 .75
Tnfsf9
KLA  ATP  ATP+KLA
 NM_009404 tumor necrosis factor (ligand) superfamily, member 9 (Tnfsf9), mRNA [NM_009404] KLA 2.77 3.30 4.20 4.18 3.31 1.37 1.43
ATP 1.15 1.37 6.05 17.64 11.37 1.90 .96
KLA/ATP 3.92 4.40 6.70 20.30 7.49 2.41 1.69
Tpo
KLA  ATP  ATP+KLA
 NM_009417 thyroid peroxidase (Tpo), mRNA [NM_009417] KLA 1.05 1.05 .87 1.01 1.00 1.03 1.04
ATP 1.03 .95 .99 1.02 1.00 1.00 .91
KLA/ATP 1.01 .99 1.01 1.01 .93 .96 .93
Tslp
KLA  ATP  ATP+KLA
 NM_021367 thymic stromal lymphopoietin (Tslp), mRNA [NM_021367] KLA 1.27 1.32 1.20 1.11 1.16 .95 .85
ATP 1.04 .97 1.02 .98 1.27 1.31 .86
KLA/ATP 1.26 1.42 1.11 1.32 1.26 1.19 .93
Vegfa
KLA  ATP  ATP+KLA
 NM_001025250 vascular endothelial growth factor A (Vegfa), transcript variant 1, mRNA [NM_001025250] KLA .49 .48 .46 .46 .39 .64 1.18
ATP 1.05 1.37 3.82 10.55 12.51 24.20 7.85
KLA/ATP .48 .59 1.45 7.42 19.75 27.42 22.35
Vegfa
KLA  ATP  ATP+KLA
 NM_001025257 vascular endothelial growth factor A (Vegfa), transcript variant 3, mRNA [NM_001025257] KLA .72 .71 .66 .70 .65 .80 1.22
ATP 1.01 1.21 3.24 11.12 11.09 18.59 5.43
KLA/ATP .68 .71 1.47 5.94 15.06 20.32 17.31
Vegfb
KLA  ATP  ATP+KLA
 NM_011697 vascular endothelial growth factor B (Vegfb), mRNA [NM_011697] KLA .65 .63 .65 .63 .52 .38 .37
ATP 1.11 1.07 1.16 1.44 1.72 1.22 .43
KLA/ATP .67 .67 .89 .90 1.19 .86 .31
Vegfc
KLA  ATP  ATP+KLA
 NM_009506 vascular endothelial growth factor C (Vegfc), mRNA [NM_009506] KLA 2.07 2.21 2.04 3.27 2.51 1.73 2.90
ATP 1.08 1.03 1.24 1.32 2.55 5.18 2.58
KLA/ATP 2.20 2.29 2.72 2.97 4.35 4.24 5.06
Xcl1
KLA  ATP  ATP+KLA
 NM_008510 chemokine (C motif) ligand 1 (Xcl1), mRNA [NM_008510] KLA 1.02 1.00 .97 1.00 1.05 1.01 1.08
ATP 1.06 .99 1.07 1.05 1.06 1.04 1.05
KLA/ATP 1.07 1.04 1.04 1.02 1.06 1.05 1.09
Xcr1
KLA  ATP  ATP+KLA
 NM_011798 chemokine (C motif) receptor 1 (Xcr1), mRNA [NM_011798] KLA 1.13 1.14 1.18 1.15 1.16 1.16 1.06
ATP 1.03 .99 1.13 1.18 1.23 1.13 1.05
KLA/ATP 1.17 1.26 1.29 1.29 1.30 1.35 1.14
Zfp91-cn
tf
KLA  ATP  ATP+KLA
 NM_001039718 zinc finger protein 91, ciliary neurotrophic factor transcription unit (Zfp91-cntf), mRNA [NM_001039718] KLA 1.28 1.20 1.20 1.31 1.23 1.38 1.21
ATP 1.22 1.17 2.26 4.25 4.44 3.73 1.90
KLA/ATP 1.44 1.39 2.22 3.89 5.86 4.63 3.25